Skip to main content
Log in

High concordance between self-reported medication and official prescription database information

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

We set out to compare the agreement between self-reported psychotropic medication use and information obtained from the administrative prescription database of the Social Insurance Institution of Finland. We compared the point prevalence of psychotropic medication use, and self-reported vs. register-based information on antipsychotic medication dosage.

Methods

The study population consisted of 905 participants from a population-based genetic study of schizophrenia, of whom 366 had schizophrenia spectrum disorder, 56 had bipolar spectrum disorder, and 483 were unaffected family members. Current medication use was obtained by interview and from the prescription reimbursement database. Agreement between data sources was compared using Cohen’s kappa statistic and correlation coefficients.

Results

The agreement between the two sources was generally good. Kappa values were best for lithium use (0.96; p < 0.0001), followed by antipsychotics (0.87; p < 0.0001) and antidepressants (0.77; p < 0.0001). Agreement was lowest for benzodiazepines (0.42; p < 0.0001). Correlation between antipsychotic medication dose estimates was 0.79 (95% CI 0.76–0.81).

Conclusion

The concordance between self-reported psychotropic medication use and information obtained from an official prescription database was good for most psychotropic drugs. More studies are needed to replicate results with other forms of medication and patient groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hallas J, Henrik S (2006) Templates for analysis of individual-level prescription data. Basic Clin Pharmacol Toxicol 98(3):260–265

    Article  PubMed  CAS  Google Scholar 

  2. Hennessy S (2006) Use of health care databases in pharmacoepidemiology. Basic Clin Pharmacol Toxicol 98(3):311–313

    Article  PubMed  CAS  Google Scholar 

  3. Hovatta I, Terwilliger JD, Lichtermann D, Mäkikyrö T, Suvisaari J, Peltonen L, Lönnqvist J (1997) Schizophrenia in the genetic isolate of Finland. Am J Med Genet 74(4):353–360

    Article  PubMed  CAS  Google Scholar 

  4. Isohanni M, Honkonen T, Vartiainen H (2001) Psykiatria [in Finnish]. In: Lönnqvist MHJ, Henriksson M et al. Karisto Oy, Hämeenlinna, p 104

  5. Jin H, Meyer JM, Jeste DV (2004) Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res 71(2–3):195–212

    Article  PubMed  Google Scholar 

  6. Lehman AF, Steinwachs DM (1998) Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull 24(1):1–10

    PubMed  CAS  Google Scholar 

  7. Løkkegaard EL, Johnsen SP, Heitmann BL, Stahlberg C, Pedersen AT, Obel EB, Hundrup YA, Hallas J, Sørensen HT (2004) The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand 83(5):476–481

    Article  PubMed  Google Scholar 

  8. Mantel-Teeuwisse AK, Klungel OH, Verschuren WM, Porsius A, de Boer A (2001) Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 54(11):1181–1186

    Article  PubMed  CAS  Google Scholar 

  9. Martikainen JPP, Pajunen R, Paldan M, Voipio T (2006) Finnish Statistics in Medicine 2005, National Agency for Medicines and Social Insurance Institution

  10. Ray WAMS, Thapa PB, Meador KG, Hall K, Murray KT (2001) Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 58:1161–1167

    Article  PubMed  CAS  Google Scholar 

  11. Rubino A, Roskell N, Tennis P, Mines D, Weich S, Andrews E (2006) Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ 334:242

    Article  PubMed  Google Scholar 

  12. Skrbo AZ, Hadzi S, Gaon ID (1999) Anatomic-therapeutic-chemical classification of drugs. Med Arh 53 [3 Suppl 3]:57–60

    PubMed  CAS  Google Scholar 

  13. Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J (2006) Antidepressants and the risk of suicide, attempted suicide and overall mortality in a nation-wide cohort. Arch Gen Psychiatry 63:1358–1367

    Article  PubMed  CAS  Google Scholar 

  14. Tiihonen J, Wahlbeck K, Lönnqvist J, Klaukka T, Ioannidis J (2006) Effectiveness of antipsychotic treatments in a nation-wide cohort of 2230 patients in community care after the first hospitalization due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 333:224

    Article  PubMed  Google Scholar 

  15. Varilo TLM, Hovatta I, Wiebe V, Terwilliger J, Peltonen L (2000) Linkage disequilibrium in isolated populations: Finland and a young sub-population of Kuusamo. Eur J Hum Gen 8:604–612

    Article  CAS  Google Scholar 

  16. WHO http://www.whocc.no/atcddd/indexdatabase/, Cited 22 May 2006

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jari Haukka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haukka, J., Suvisaari, J., Tuulio-Henriksson, A. et al. High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol 63, 1069–1074 (2007). https://doi.org/10.1007/s00228-007-0349-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-007-0349-6

Keywords

Navigation